Gedeon Richter PLC (FRA:RIG2)

Market Cap	5.57B +22.4%
Revenue (ttm)	2.31B +7.4%
Net Income	582.91M +7.4%
EPS	3.18 +7.3%
Shares Out	n/a
PE Ratio	9.55
Forward PE	7.76
Dividend	1.26 (4.14%)
Ex-Dividend Date	Jun 3, 2025

Volume	n/a
Average Volume	135
Open	30.88
Previous Close	31.38
Day's Range	30.88 - 30.88
52-Week Range	22.94 - 31.58
Beta	n/a
RSI	64.13
Earnings Date	Feb 27, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic ...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 10,943
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RIG2

Financial Performance

In 2024, Gedeon Richter's revenue was 857.55 billion, an increase of 6.51% compared to the previous year's 805.16 billion. Earnings were 239.24 billion, an increase of 50.61%.

Financial numbers in HUF